Suppression of GSK-3 by treatment with the GSK-3 inhibitor SB415286 suppressed motility, proliferation and colony formation in PC3 prostate cancer cells which express large amounts of activated Akt due to PTEN deletion. This evidence concerns the gene AKT1 and prostate cancer.